Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of $748.82 million. The enterprise value is $778.52 million.
| Market Cap | 748.82M |
| Enterprise Value | 778.52M |
Important Dates
The next confirmed earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Evolus has 62.61 million shares outstanding. The number of shares has increased by 4.11% in one year.
| Shares Outstanding | 62.61M |
| Shares Change (YoY) | +4.11% |
| Shares Change (QoQ) | +2.70% |
| Owned by Insiders (%) | 12.70% |
| Owned by Institutions (%) | 81.34% |
| Float | 44.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.41 |
| Forward PS | n/a |
| PB Ratio | 40.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 6.87.
| Current Ratio | 3.21 |
| Quick Ratio | 2.80 |
| Debt / Equity | 6.87 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -31.90% |
| Return on Capital (ROIC) | -31.78% |
| Revenue Per Employee | $804,751 |
| Profits Per Employee | -$219,791 |
| Employee Count | 273 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 3.86 |
Taxes
In the past 12 months, Evolus has paid $200,000 in taxes.
| Income Tax | 200,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.58% in the last 52 weeks. The beta is 1.30, so Evolus's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | +57.58% |
| 50-Day Moving Average | 11.94 |
| 200-Day Moving Average | 11.41 |
| Relative Strength Index (RSI) | 57.36 |
| Average Volume (20 Days) | 504,611 |
Short Selling Information
The latest short interest is 4.75 million, so 7.59% of the outstanding shares have been sold short.
| Short Interest | 4.75M |
| Short Previous Month | 4.54M |
| Short % of Shares Out | 7.59% |
| Short % of Float | 10.57% |
| Short Ratio (days to cover) | 8.25 |
Income Statement
In the last 12 months, Evolus had revenue of $219.70 million and -$60.00 million in losses. Loss per share was -$1.04.
| Revenue | 219.70M |
| Gross Profit | 152.22M |
| Operating Income | -46.12M |
| Pretax Income | -59.80M |
| Net Income | -60.00M |
| EBITDA | -38.05M |
| EBIT | -44.06M |
| Loss Per Share | -$1.04 |
Balance Sheet
The company has $96.96 million in cash and $126.65 million in debt, giving a net cash position of -$29.69 million or -$0.47 per share.
| Cash & Cash Equivalents | 96.96M |
| Total Debt | 126.65M |
| Net Cash | -29.69M |
| Net Cash Per Share | -$0.47 |
| Equity (Book Value) | 18.44M |
| Book Value Per Share | 0.29 |
| Working Capital | 103.46M |
Cash Flow
In the last 12 months, operating cash flow was -$24.04 million and capital expenditures -$1.91 million, giving a free cash flow of -$25.95 million.
| Operating Cash Flow | -24.04M |
| Capital Expenditures | -1.91M |
| Free Cash Flow | -25.95M |
| FCF Per Share | -$0.44 |
Margins
Gross margin is 69.28%, with operating and profit margins of -20.99% and -27.31%.
| Gross Margin | 69.28% |
| Operating Margin | -20.99% |
| Pretax Margin | -27.22% |
| Profit Margin | -27.31% |
| EBITDA Margin | -17.32% |
| EBIT Margin | -20.05% |
| FCF Margin | -11.81% |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.11% |
| Shareholder Yield | -4.11% |
| Earnings Yield | -8.01% |
| FCF Yield | -3.47% |
Analyst Forecast
The average price target for Evolus is $22.60, which is 88.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.60 |
| Price Target Difference | 88.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 27.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -0.5 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.5 |
| Piotroski F-Score | 4 |